Surgery

Medicine & Life Sciences

1. Liver 100%
2. Gastrectomy 97%
3. Hepatocellular Carcinoma 89%
4. Robotics 73%
5. Rectal Neoplasms 67%
6. Stomach Neoplasms 57%
7. Hepatectomy 52%
8. Chemoradiotherapy 44%
9. Neoplasms 37%
10. Neoplasm Metastasis 35%
11. Drug Therapy 34%
12. Esophagectomy 34%
13. Propensity Score 33%
14. Colorectal Neoplasms 27%
15. Minimally Invasive Surgical Procedures 27%
16. Recurrence 27%
17. Gastrointestinal Stromal Tumors 23%
18. Squamous Cell Carcinoma 22%
19. Liver Diseases 19%
20. Surgeons 19%
21. Morbidity 19%
22. Lymph Node Excision 18%
23. Pathologic Constriction 17%
24. Gastroenterostomy 17%
25. Cholangiocarcinoma 17%
26. Lymph Nodes 17%
27. Survival 17%
28. Laparoscopy 16%
29. Chronic Disease 16%
30. Segmental Mastectomy 16%
31. Fibrosis 16%
32. Retrospective Studies 16%
33. Carcinoma 15%
34. Esophageal Neoplasms 15%
35. Breast 15%
36. Imatinib Mesylate 14%
37. Liver Transplantation 13%
38. Therapeutics 12%
39. Survival Rate 12%
40. Colonic Neoplasms 11%
41. Tomography 11%
42. Hepatic Veins 11%
43. Ascites 11%
44. Liver Cirrhosis 10%
45. Observational Studies 10%
46. Cohort Studies 10%
47. Japan 10%
48. Colectomy 10%
49. Postoperative Complications 10%
50. Fluorouracil 10%
51. Ileitis 9%
52. Liver Neoplasms 9%
53. Rectocele 9%
54. Dissection 9%
55. Angiodysplasia 9%
56. Ischemic Colitis 9%
57. Child 9%
58. Focal Nodular Hyperplasia 9%
59. Klatskin Tumor 9%
60. Stomach 9%
61. Operative Time 9%
62. Breast Implants 8%
63. Intraoperative Monitoring 8%
64. Recurrent Laryngeal Nerve 8%
65. Ascending Colon 8%
66. Diverticulitis 8%
67. Combined Modality Therapy 8%
68. Cardiac Tamponade 8%
69. Cholecystitis 8%
70. Length of Stay 8%
71. Upper Gastrointestinal Tract 8%
72. Curriculum 8%
73. Gastrointestinal Motility 8%
74. Nomograms 8%
75. Virtual Reality 8%
76. Skin 7%
77. Nipples 7%
78. Triple Negative Breast Neoplasms 7%
79. Silicon 7%
80. Liver Failure 7%
81. Fistula 7%
82. Tissue Expansion Devices 7%
83. Perioperative Period 7%
84. Radiotherapy 7%
85. Pancreaticoduodenectomy 7%
86. Safety 7%
87. Transanal Endoscopic Surgery 7%
88. Technology 7%
89. Mammaplasty 7%
90. Neoadjuvant Therapy 7%
91. Prolapse 7%
92. Irinotecan 7%
93. Carcinoembryonic Antigen 7%
94. Biliary Tract 7%
95. Weight Loss 7%
96. Sigmoid Colon 7%
97. S 1 (combination) 7%
98. Sarcoidosis 7%
99. Venous Thromboembolism 7%
100. Small Intestine 7%